Last Updated: November 9, 2026

AMINOCAPROIC ACID IN PLASTIC CONTAINER Drug Patent Profile

« Back to Dashboard


Which patents cover Aminocaproic Acid In Plastic Container, and what generic alternatives are available?

Aminocaproic Acid In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in AMINOCAPROIC ACID IN PLASTIC CONTAINER is aminocaproic acid. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aminocaproic Acid In Plastic Container

A generic version of AMINOCAPROIC ACID IN PLASTIC CONTAINER was approved as aminocaproic acid by LUITPOLD on December 1st, 1987.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for AMINOCAPROIC ACID IN PLASTIC CONTAINER?
  • What are the global sales for AMINOCAPROIC ACID IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for AMINOCAPROIC ACID IN PLASTIC CONTAINER?
Summary for AMINOCAPROIC ACID IN PLASTIC CONTAINER
Recent Clinical Trials for AMINOCAPROIC ACID IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zagazig UniversityNA
Minia UniversityPhase 3
NYU Langone HealthN/A

See all AMINOCAPROIC ACID IN PLASTIC CONTAINER clinical trials

Pharmacology for AMINOCAPROIC ACID IN PLASTIC CONTAINER
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis

US Patents and Regulatory Information for AMINOCAPROIC ACID IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira AMINOCAPROIC ACID IN PLASTIC CONTAINER aminocaproic acid INJECTABLE;INJECTION 070010-001 Mar 9, 1987 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.